HIRAMATSU Naoki | Department of Gastroenterology and Hepatology, Osaka University Graduate School of Medicine
スポンサーリンク
概要
- HIRAMATSU Naokiの詳細を見る
- 同名の論文著者
- Department of Gastroenterology and Hepatology, Osaka University Graduate School of Medicineの論文著者
関連著者
-
HIRAMATSU Naoki
Department of Gastroenterology and Hepatology, Osaka University Graduate School of Medicine
-
Hiramatsu Naoki
Department Of Gastroenterology And Hepatology Osaka University Graduate School Of Medicine
-
HAYASHI Norio
Department of Biochemistry, Tohoku University School of Medicine
-
Hiramatsu Naoki
大阪大学 医学系研究科消化器内科
-
Hayashi Noriyuki
Department Of Gastroenterology And Hepatology Osaka University Graduate School Of Medicine
-
Kanto Tatsuya
Department Of Gastroenterology And Hepatology Osaka University Graduate School Of Medicine
-
Takehara Tetsuo
Department Of Gastroenterology And Hepatology Osaka University Graduate School Of Medicine
-
KANTO Tatsuya
Department of Gastroenterology and Hepatology, Osaka University Graduate School of Medicine
-
Toyama Tetsuya
Department Of Gastroenterology And Hepatology Osaka University
-
TAKEHARA Tetsuo
Department of Gastroenterology and Hepatology, Osaka University
著作論文
- Lamivudine-to-entecavir switching treatment in type B chronic hepatitis patients without evidence of lamivudine resistance
- Factors contributing to antiviral effect of adefovir dipivoxil therapy added to ongoing lamivudine treatment in patients with lamivudine-resistant chronic hepatitis B
- Effect of interferon α-2b plus ribavirin therapy on incidence of hepatocellular carcinoma in patients with chronic hepatitis
- Serum levels of soluble major histocompatibility complex (MHC) class I-related chain A in patients with chronic liver diseases and changes during transcatheter arterial embolization for hepatocellular carcinoma
- Early emergence of entecavir-resistant hepatitis B virus in a patient with hepatitis B virus/human immunodeficiency virus coinfection
- Early decline of hemoglobin can predict progression of hemolytic anemia during pegylated interferon and ribavirin combination therapy in patients with chronic hepatitis C
- Early decline of hemoglobin correlates with progression of ribavirin-induced hemolytic anemia during interferon plus ribavirin combination therapy in patients with chronic hepatitis C
- Reduced expression and functional impairment of Toll-like receptor 2 on dendritic cells in chronic hepatitis C virus infection
- Should aged patients with chronic hepatitis C be treated with interferon and ribavirin combination therapy?
- The significance of interferon and ribavirin combination therapy followed by interferon monotherapy for patients with chronic hepatitis C in Japan